Related Experiment Videos
Vasopressin in hemorrhagic shock
1Department of Anaesthesiology & Critical Care, Armed Forces Medical College, Pune, India.
Anesthesia and Analgesia
|August 24, 2005
Summary
Small-dose vasopressin effectively treated two patients with hemorrhagic shock resistant to standard therapies. This approach allowed for reduced catecholamine use, suggesting a potential new treatment strategy for refractory shock.
Area of Science:
- Critical Care Medicine
- Emergency Medicine
- Pharmacology
Background:
- Hemorrhagic shock requires aggressive fluid resuscitation and often vasopressor support.
- Refractory cases pose significant management challenges, necessitating alternative therapeutic options.
Observation:
- Two patients presented with severe hemorrhagic shock unresponsive to conventional volume replacement and catecholamine infusions.
- Administration of low-dose vasopressin infusions resulted in a significant clinical response in both patients.
Findings:
- Vasopressin at small doses successfully stabilized hemodynamics in catecholamine-resistant hemorrhagic shock.
- The use of vasopressin enabled a reduction in the dosage of concurrent catecholamine infusions.
Implications:
- Low-dose vasopressin may represent a valuable adjunct therapy for fluid- and catecholamine-resistant hemorrhagic shock.
- Further research is warranted to elucidate the precise role and optimal dosing of vasopressin in managing refractory shock states.